Safety and Efficacy of BGP-15 in Patients With Type 2 Diabetes Mellitus

Stopped Funding support withdrawn.

Conditions

• Diabetes Mellitus

Interventions

• DRUG: BGP-15 100 mg QD
• DRUG: BGP-15 100 mg BID
• DRUG: Placebo BID
• DRUG: BGP-15 200 mg QD
• DRUG: BGP-15 200 mg BID
• DRUG: BGP-15 400 mg QD

Sponsor

N-Gene Research Laboratories, Inc.

Collaborators

• [object Object]
• [object Object]
• [object Object]
• [object Object]
• [object Object]
• [object Object]